Kukje Pharma국제약품
002720 · KOSPI · ₩002720 · 국제약품
- Market cap
- ₩71B
- Enterprise value
- ₩83B
- P/E
- 14.2×
- P/B
- 0.7×
- Dividend yield
- 0.9%
- ROE
- 5.0%
- Net margin
- 2.8%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−38.8% from the high
₩2,810Today: ₩3,260 – ₩3,405₩5,470
Returns
- 1W−5.6%
- 1M+3.9%
- 3M+5.4%
- 6M−29.0%
- YTD−22.2%
- 1Y−20.5%
- Volume today
- 442,505
- 0.1× the 20-day average
- Traded today
- ₩1.5B
- Listed shares
- 21,159,832
- EPS (12 months)
- ₩236
- Earnings yield 7.1%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 26 of 100 (50 is a normal day for this stock).
- MomentumFlat3.1% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
Kukje Pharma stock overview
Kukje Pharma (국제약품, KRX: 002720) is listed on KOSPI, in the Biotech & Pharma sector. The company manufactures and sells pharmaceuticals, including prescription and over-the-counter drugs such as Curlon eye drops, Colencina soft capsules, Ezerva tablets, Identzlt injection, and Retium tablets. Its shares closed at ₩3,345 on Oct 30, 2026, down 1.62% on the day, giving it a market value of ₩71B.
Key facts
- Market cap
- ₩71B
- Sector
- Biotech & Pharma
- Latest price change
- −1.62%
- As of
- Oct 30, 2026
- Main business
- The company manufactures and sells pharmaceuticals, including prescription and over-the-counter drugs such as Curlon eye drops, Colencina soft capsules, Ezerva tablets, Identzlt injection, and Retium tablets.
Quick answers about Kukje Pharma
- What does Kukje Pharma do?
- The company manufactures and sells pharmaceuticals, including prescription and over-the-counter drugs such as Curlon eye drops, Colencina soft capsules, Ezerva tablets, Identzlt injection, and Retium tablets. Headquartered in Seongnam, Gyeonggi-do, it produces its products at its own facility in Ansan and sells them through regional sales teams to pharmacies, clinics, hospitals, and wholesalers across Korea.
- What is the market cap of Kukje Pharma?
- The market capitalisation of Kukje Pharma was ₩71B at the close on Oct 30, 2026.
- Who are the largest shareholders of Kukje Pharma?
- According to the latest official filings, the largest reported holders are Nam Tae-hoon (10.70%, as of Oct 8, 2026); National Pension Service (0.33%, as of Dec 31, 2025); Kim Sung-gyu (0.31%, as of Jun 5, 2026).
- When is the next earnings report from Kukje Pharma?
- Korean companies rarely announce results dates in advance. Based on when Kukje Pharma filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
- Does the National Pension Service own Kukje Pharma?
- Yes. The National Pension Service held 0.33% of Kukje Pharma shares as of Dec 31, 2025.
Company profile
The company manufactures and sells pharmaceuticals, including prescription and over-the-counter drugs such as Curlon eye drops, Colencina soft capsules, Ezerva tablets, Identzlt injection, and Retium tablets. Headquartered in Seongnam, Gyeonggi-do, it produces its products at its own facility in Ansan and sells them through regional sales teams to pharmacies, clinics, hospitals, and wholesalers across Korea.
Written by AI from the company's latest annual report.
- Korean name
- 국제약품
- Sector
- Biotech & Pharma
- Themes
- Pharmaceuticals
- CEO
- 남태훈
- Founded
- Jul 1959
- Listed
- Dec 1975
- Listed shares
- 21,159,832
- Fiscal year ends
- Month 12
- Website
- www.kukjepharm.co.kr
Similar companies
- Samsung Biologics207940 · ₩69T₩1,487,000+8.86%
- Celltrion068270 · ₩44T₩191,600+1.22%
- Alteogen196170 · ₩15T₩211,500−3.86%
- SK biopharmaceuticals326030 · ₩6.1T₩77,700−0.13%
- Yuhan000100 · ₩5.5T₩75,100+0.54%
- HLB028300 · ₩5.3T₩40,000+0.76%
- Hanmi Pharm128940 · ₩5.3T₩415,000+6.82%
- SAM Chun Dang Pharm000250 · ₩4.3T₩182,700−3.13%
Recent filings
See all- Insider shareholding reportOct 8, 2026
- Insider shareholding reportOct 8, 2026
- 5%+ holding reportOct 7, 2026
- Change of largest shareholderOct 6, 2026
- Change in largest shareholder's holdingsOct 6, 2026
Titles in Korean until English translations are added.
Also known as: Kukje Pharma / 국제약품 / 002720 / KRX:002720
Source: KRX statistical information